Status:
UNKNOWN
PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Oxford University Hospitals NHS Trust
University Hospitals, Leicester
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The PERFORM study is a pilot study investigating the feasibility and usefulness of performing a novel CT (Computed Tomography)scanning technique called Perfusion CT(CTP) as an addition to normal CT sc...
Eligibility Criteria
Inclusion
- Patients who have given written informed consent to participate in the FOXFIRE clinical trial and have not yet started chemotherapy treatment in the trial.
- Serum creatinine and calculated glomerular filtration rate are less than the upper limit of normal (ULN) in blood tests performed up to 29 days before entry into the FOXFIRE clinical trial.
- Liver metastasis 1.0 to4.0 cm in cranio-caudal diameter on imaging performed up to 29 days before entry into the FOXFIRE clinical trial
Exclusion
- True allergy to intravenous iodinated CT contrast
- Active medical or psychological illness that would render the patient unsuitable for the additional imaging proposed in this pilot study, at the discretion of the investigator
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01410760
Start Date
April 1 2011
Last Update
June 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Radcliffe Hospitals NHS Trust
Oxford, United Kingdom, OX3 7LJ